1) Cho HJ, Bloomberg J, Nichols J. Giant cell arteritis. Dis Mon. 2017;63(3):88–91.
2) Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the
classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128.
3) Watelet B, Samson M, de Boysson H, Bienvenu B. Treatment of giant-cell arteritis, a literature review.
Mod Rheumatol. 2017;27(5):747–754.
4) Kobayashi S, Yano T, Matsumoto Y, et al. Clinical and epidemiologic analysis of giant cell (temporal)
arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey.
Arthritis Rheum. 2003;49(4):594–598.
5) Dinesh KP, Owolabi A, Dwyer-Joyce L, Cronin PM, Schimmer BM, Mo GP. Temporal artery vasculitis in
young: a report of two cases. Rheumatol Int. 2010;30(10):1393–1396.
6) Dogra M, Singh R, Dogra MR. Giant cell arteritis related arteritic anterior ischemic optic neuropathy:
clinico-pathological correlation. Indian J Ophthalmol. 2019;67(1):142.
7) Yoon HJ, Park SW, Lee HK, Choi YD, Heo H. Bilateral arteritic anterior ischemic optic neuropathy
associated with giant cell arteritis in Korea. Korean J Ophthalmol. 2017;31(5):466.
8) Skanchy DF, Vickers A, Claudia M, Ponce P, Lee AG. Ocular manifestations of giant cell arteritis. Expert
Rev Ophthalmol. 2019;14(1):23–32.
149
Giant cell arteritis with focal pachymeningitis
9) Zachariades N, Skoura C, Spanou A, Machera H. Temporal arteritis: report of a case. Oral Surgery Oral
Med Oral Pathol Oral Radiol Endod. 2006;102(2):192–197.
10) Thurtell MJ, Longmuir RA. Third nerve palsy as the initial manifestation of giant cell arteritis. J Neuroophthalmology. 2014;34(3):243–245.
11) Gerstle CC, Friedman AH. Marginal corneal ulceration (limbal guttering) as a presenting sign of temporal
arteritis. Ophthalmology. 1980;87(11):1173–1176.
12) Hsu YW, Yang FC, Lee JT, Kao HW, Tsai CK. Orbital cellulitis presenting as giant cell arteritis: a case
report. Acta Neurol Taiwan. 2017;26(2):72–75.
13) Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the
United Kingdom, 1990–2001. Ann Rheum Dis. 2006;65(8):1093–1098.
14) Elling P, Olsson AT, Elling H. Synchronous variations in the incidence of temporal arteritis and polymyalgia
rheumatica in Danish counties. Association with epidemics of Mycoplasma pneumonia infection [in Danish].
Ugeskr Laeger. 1997;159(26):4123–4128.
15) Joelson E, Ruthrauff B, Ali F, Lindeman N, Sharp FR. Multifocal dural enhancement associated with
temporal arteritis. Arch Neurol. 2000;57(1):119–122.
16) Marano E, D’Armiento FP, Scarano V, Tortora F, Mignogna C, Briganti F. Focal hypertrophic cranial
pachymeningitis associated with temporal arteritis: a new case report. J Neurol. 2003;250(1):98–100.
17) Brass SD, Durand ML, Stone JH, Chen JW, Stone JR. Case 36-2008: a man with chronic daily headache.
N Engl J Med. 2008;359(21):2267–2278.
18) Kuhn J, Harzheim A, Brockmann M, Mahkorn D, Bewermeyer H. Focal hypertrophic pachymeningitis in
association with temporal arteritis. Headache. 44(10):1045–1048.
19) Tokushige S, Matsuura H, Hideyama T, Tamura K, Maekawa R, Shiio Y. Hypertrophic pachymeningitis as
a potential cause of headache associated with temporal arteritis. Intern Med. 2016;55(5):523–526.
20) Uribe JA, Aggarwal I, Witthayaweerasak J, Liao YJ, Berry GJ, Sab UK. Weynad CM.Refractory giant cell
arteritis complicated by vision loss from optic atrophy and maculopathy associated with pachymeningitis.
J Neurophthalmol. 2018;38(1):17–23.
21) Gordon M, Gordon EP. Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (case report).
J Am Geriatr Soc. 1980;28(3):136–138.
22) Roelcke U, Eschle D, Kappos L, Moschopulos M, Laeng RH, Buettner UW. Meningoradiculitis associated
with giant cell arteritis. Neurology. 2002;59(11):1811–1812.
23) Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries.
Arthritis Rheum. 2006;55(6):985–989.
24) Larivière D, Sacre K, Klein I, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis. Medicine
(Baltimore). 2014;93(28):e265.
25) Alsolaimani RS, Bhavsar SV, Khalidi NA, et al. Severe intracranial involvement in giant cell arteritis: 5
cases and literature review. J Rheumatol. 2016;43(3):648–656.
26) Kargiotis O, Safouris A, Petrou VN, Magoufis G, Stamboulis E, Tsivgoulis G. Teaching Neuro Images:
giant cell arteritis presenting with acute ischemic strokes due to diffuse intracranial stenoses. Neurology.
2017;89(15):e190–e191.
27) Kudo T, Yoshinaga K, Takeishi Y, Nakajima K. Statement on 18F-FDG PET usage for large-vessel vasculitis.
Ann Nucl Cardiol. 2018;4(1):46–51.
28) Allsop CJ, Gallagher PJ. Temporal artery biopsy in giant-cell arteritis: a reappraisal. AmJSurgPathol.
1981;5(4):317–323.
29) Borchers AT, Gershwin ME. Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology
and treatment. Autoimmun Rev. 2012;11(6–7):A544–A554.
30) Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: eventual diagnoses and features of
patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol.
2008;26(6):1103–1106.
31) Bowling K, Rait J, Atkinson J, Srinivas G. Temporal artery biopsy in the diagnosis of giant cell arteritis:
does the end justify the means? Ann Med Surg(Lond). 2017;20:1–5.
32) Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE. How does previous corticosteroid treatment
affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med.1994;120(12):987–982.
33) Narváez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery
biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37(1):13–19.
34) Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an
individual patient data meta-analysis. Arthritis Rheum. 2007;56(8):2789–2797.
35) Fytili C, Bournia VK, Korkou C, Pentazos G, Kokkinos A. Multiple cranial nerve palsies in giant cell
150
Raja K Kutty et al
arteritis and response to cyclophosphamide: a case report and review of the literature. Rheumatol Int.
2015;35(4):773–776.
36) Imrich R, Bosak V, Rovensky` J. Polymyalgia rheumatica and giant cell arteritis. Endocr Regul.
2006;40(3):63–69.
37) Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med.
2017;377(4):317–328.
...